On February 01, 2022, PharmaShots will present the second interview in its new interview section, “Spotlight- Company of the Month’’.
Company of the month is our new exclusive feature under which we are interviewing the key leaders of the start-ups that are providing fierce solutions. We pick one company every month and interview them about their journey, products, and solutions, and upcoming plans. The interview will highlight the company’s innovative activities and technology.
The coming interview is scheduled with Michael Sassano, CEO and Chairman of the Board for Somai Pharmaceuticals. We will discuss the story of Somai Pharma, its upcoming plans, achievements and the journey.
SOMAÍ Pharmaceuticals is a large-scale manufacturer of cannabis products, concentrating on the highest quality medical-grade pharmacological applications. The company extracts and purifies bulk primary APIs of THC, THCa, CBD, CBN and other cannabinoids from the finest chosen cannabis flower. SOMAÍ’s proprietary formulations have multiple combinations of cannabinoid concentrations which can be delivered by gel capsules, drops, transdermal patches and other innovative delivery methods.
About Michael Sassano:
Michael Sassano is the current CEO and Chairman of the Board for Somai Pharmaceuticals LTD, a European company focused on extraction and manufacturing of cannabinoid-containing pharmaceutical products throughout the EU. Before turning his attention to Europe, Michael was the Founder and CEO of Solaris Farms, one of the largest and most technologically advanced cannabis cultivation companies in the state of Nevada in the United States. In addition, He is an early investor in the cannabis industry, known today across the globe as an international authority on large-scale cannabis cultivation and medical product development.
Related Post: Spotlight Interview with Chris Dokomajilar, CEO and Founder of DealForma
